Buscar
image du produit
American Journal of Surgery

Suscribirse

Factors associated with physicians’ recommendations for managing low-risk papillary thyroid cancer - 15/06/21

Doi : 10.1016/j.amjsurg.2020.11.021 
Alexandria D. McDow a, ⁎ , Benjamin R. Roman b , Megan C. Saucke c , Catherine B. Jensen c , Nick Zaborek d , Jamia Linn Jennings e , Louise Davies f , Juan P. Brito g , Susan C. Pitt c
a Division of Surgery Oncology, Department of Surgery, Indiana University School of Medicine, 545 Barnhill Drive EH 537, Indianapolis, IN, 46202, USA 
b Division of Head and Neck, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA 
c Department of Surgery, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave., Madison, WI, 53792, USA 
d Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave., Madison, WI, 53792, USA 
e Wisconsin Department of Health Services, 1 West Wilson Street, Madison, WI, 53703, USA 
f The VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, VT, USA and The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH, 1 Medical Center Drive, Lebanon, NH, 03756, USA 
g Division of Diabetes, Endocrinology, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA 

∗Corresponding author. Indiana University School of Medicine, Department of Surgery - Division of Surgical Oncology, 545 Barnhill Drive EH 537, Indianapolis, IN, 46202, USA.Indiana University School of MedicineDepartment of Surgery - Division of Surgical Oncology545 Barnhill Drive EH 537IndianapolisIN46202USA

Abstract

Background

The 2015 American Thyroid Association endorsed less aggressive management for low-risk papillary thyroid cancer (LR-PTC). We aimed to identify factors influencing physicians’ recommendations for LR-PTC.

Methods

We surveyed members of three professional societies and assessed respondents’ recommendations for managing LR-PTC using patient scenarios. Multivariable logistic regression models identified clinical and non-clinical factors associated with recommending total thyroidectomy (TT) and active surveillance (AS).

Results

The 345 respondents included 246 surgeons and 99 endocrinologists. Physicians’ preference for their own management if diagnosed with LR-PTC had the strongest association with their recommendation for TT and AS (TT: OR 12.3; AS: OR 7.5, p < 0.001). Physician specialty and stated patient preference were also significantly associated with their recommendations for both management options. Respondents who received information about AS had increased odds of recommending AS.

Conclusions

Physicians’ recommendations for LR-PTC are strongly influenced by non-clinical factors, such as personal treatment preference and specialty.

El texto completo de este artículo está disponible en PDF.

Highlights

•
Physician recommendations for low-risk papillary thyroid cancer are multifactorial.
•
Physicians’ personal treatment preference is associated with their recommendations.
•
Physician specialty and stated patient preference also influence recommendations.

El texto completo de este artículo está disponible en PDF.

Keywords : Thyroid cancer, Overtreatment, Low-risk, Active surveillance, Survey, Thyroidectomy


Esquema


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

    •

  • Contenido

    •

Vol 222 - N° 1

P. 111-118 - juillet 2021 Regresar al número
Artículo precedente Artículo precedente
  • A longitudinal cadaver-based simulation curriculum creates sustainable increases in resident confidence and exposure to fundamental techniques: Results of a 5-year program evaluation
  • Brendan P. Lovasik, Steven C. Kim, Vivian L. Wang, Katherine T. Fay, Matthew T. Santore, Keith A. Delman, Jahnavi K. Srinivasan
| Artículo siguiente Artículo siguiente
  • Analysis of adjuvant chemotherapy in patients undergoing curative-intent resection of localized adrenocortical carcinoma
  • Ali Al Asadi, Daniel M. Hubbs, Patrick J. Sweigert, Marshall S. Baker, Adam S. Kabaker

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta

Aide & support

Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.

Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.